(Q57626457)

English

Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Soc

article

In more languages

Statements

scholarly article

0 references

Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Soc (English)

0 references

0 references

0 references

electrophysiology

1 reference

based on heuristic

inferred from title

Michele Gulizia

object named as

Michele Gulizia

7

0 references

Christian Sticherling

object named as

Christian Sticherling

1

0 references

object named as

Vanessa Roldan

13

0 references

Giuseppe Boriani

object named as

Giuseppe Boriani

4

0 references

Karl-Heinz Kuck

10

object named as

Karl-Heinz Kuck

0 references

Gerhard Hindricks

9

object named as

Gerhard Hindricks

0 references

5

object named as

Hugh Calkins

0 references

Tatjana S Potpara

12

object named as

Tatjana Potpara

0 references

Francisco Marín

2

object named as

Francisco Marin

0 references

15

object named as

Gregory Y.H. Lip

0 references

Gheorghe-Andrei Dan

6

object named as

Gheorghe-Andrei Dan

0 references

Sigrun Halvorsen

8

object named as

Sigrun Halvorsen

0 references

author name string

David Birnie

3

0 references

Angel Moya

11

0 references

Roland Tilz

14

0 references

publication date

23 June 2015

0 references

0 references

17

0 references

8

0 references

1197-1214

0 references

Consensus document on antithrombotic therapy in the setting of electrophysiological procedures

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design:

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Stroke and thromboembolism in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Circumferential pulmonary-vein ablation for chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Current periprocedural management of ablation for atrial fibrillation in Europe: results of the European Heart Rhythm Association survey

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) P

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Best practice for atrial fibrillation patient education

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Atrial fibrillation ablation in patients with therapeutic international normalized ratios

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Safety of continuous periprocedural rivaroxaban for patients undergoing left atrial catheter ablation procedures.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Periprocedural management of new oral anticoagulants in patients undergoing atrial fibrillation ablation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Incidence of left atrial thrombus prior to atrial fibrillation ablation: is pre-procedural transoesophageal echocardiography mandatory?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Atrial fibrillation ablation using open-irrigated tip radiofrequency: experience with intraprocedural activated clotting times ≤210 seconds

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

High-flow perfusion of sheaths for prevention of thromboembolic complications during complex catheter ablation in the left atrium.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Letter by May et al regarding article, "Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation" by Bassiouny et al.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Atrial fibrillation is common after ablation of isolated atrial flutter during long-term follow-up.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

The 1998 NASPE prospective catheter ablation registry

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardi

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Femoral vein thrombosis after right-sided electrophysiological procedures

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Ablation of idiopathic right ventricular outflow tract tachycardia: current perspectives

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Electrocardiographic predictors of long-term outcomes after radiofrequency ablation in patients with right-ventricular outflow tract tachycardia.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Idiopathic right ventricular arrhythmias not arising from the outflow tract: prevalence, electrocardiographic characteristics, and outcome of catheter ablation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (H

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Epicardial ablation for ventricular tachycardia: a European multicenter study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia's project

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Predictors of stroke in patients paced for sick sinus syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Cardiac-resynchronization therapy for mild-to-moderate heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Management of antithrombotic therapy in patients undergoing electrophysiological device surgery

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Pacemaker or defibrillator surgery without interruption of anticoagulation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Meta-analysis of continuous oral anticoagulants versus heparin bridging in patients undergoing CIED surgery: reappraisal after the BRUISE study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

The safety and efficacy of antithrombotic therapy in patients undergoing cardiac rhythm device implantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Preven

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Meta-analysis of bleeding complications associated with cardiac rhythm device implantation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Is antiarrhythmia device implantation safe under dual antiplatelet therapy?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Management of bleeding in patients receiving conventional or new anticoagulants: a practical and case-based approach

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

How I treat target-specific oral anticoagulant-associated bleeding.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Reversal of anticoagulants: an overview of current developments.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Evaluation of patients' attitudes towards stroke prevention and bleeding risk in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Explaining risks: turning numerical data into meaningful pictures

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Health technology assessment: what is it? Current status and perspectives in the field of electrophysiology

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

The cost of illness of atrial fibrillation: a systematic review of the recent literature

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

The cost-utility of catheter ablation of atrial fibrillation: a systematic review and critical appraisal of economic evaluations

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Gro

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy: Results of a prospective, two-centre registry

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Risk of hematoma complications after device implant in the clopidogrel era.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Antithrombotic or anti-platelet agents in patients undergoing permanent pacemaker implantation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Heparin Bridging vs. Uninterrupted Oral Anticoagulation in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Patient Preference-based Treatment Thresholds and Recommendations

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Increased Intensity of Anticoagulation May Reduce Risk of Thrombus During Atrial Fibrillation Ablation Procedures in Patients with Spontaneous Echo Contrast

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Economic evaluation in cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Ablation of Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV190

21 January 2018

Identifiers

10.1093/EUROPACE/EUV190

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57626457&oldid=1997982776"